How telehealth providers can drive antibiotic overuse

Antibiotic overuse contributes to the growing threat of drug-resistant microbes, which kill more than 35,000 people in the U.S. every year.

April 11, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | Telehealth providers can drive antibiotic overuse — or choose to combat it Studies show patients who use a direct-to-consumer telehealth visit are more likely to receive an antibiotic. CDC renews guidelines to prevent overuse. By Katie Palmer STAT+ | Medicare expects to spend $3.5 billion on new Alzheimer's drug in 2025 Medicare projections on spending for new Alzheimer's drug outpaces estimates from Wall Street and the drug manufacturers Eisai, Biogen. By Bob Herman and Rachel Cohrs Zhang $10 billion long Covid 'moonshot' is being floated by Bernie Sanders  The Vermont senator has proposed a new long Covid research program at the NIH, to help scientists developing much-needed therapies. By Isabella Cueto Scott McIntyre for STAT STAT+ | When a cancer drug fails, oncologists often fly blind. A precision technique might light the way A study of children with cancer shows that testing tumor cells against hundreds of drugs, called functional precision medicine, can have great benefit. By Angus Chen Opinion: To rebuild trust in public health: Better communication, fewer mandates, and small wins The more trust that can be restored in the CDC and public health, the faster and more effectively the country can respond to emergencies. By Tom Frieden STAT+ | European Parliament votes in favor of updated pharma legislation, prompting mixed reactions The European Consumer Organization complained the effort does not go far enough to make meaningful changes. By Ed Silverman Listen: Vertex's big deal, biotech's red numbers, & an industry history lesson This episode, we discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. By Damian Garde, Allison DeAngelis, and Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser